Literature DB >> 6451633

Increased clearance and degradation of [3H]insulin in streptozotocin diabetic rats.

J Philippe, P A Halban, A Gjinovci, W C Duckworth, J Estreicher, A E Renold.   

Abstract

The role of the insulin-receptor compartment in the pharmacokinetics of intravenously injected insulin in rats was studied. Since streptozotocin-diabetes in rats results in increased insulin binding to tissues in vitro, insulin pharmacokinetics in streptozotocin-diabetic rats were compared to controls, using semisynthetic [(3)H]insulin as the tracer. The initial distribution volume for [(3)H]insulin was elevated by 60% in diabetic rats. By contrast, no difference in initial distribution volume for [(14)C]inulin was observed, and the absolute values were lower than those found for [(3)H]insulin. The metabolic clearance rate of [(3)H]insulin was elevated by 44% in diabetic rats. That these differences were the result of increased binding of insulin to a specific receptor compartment in diabetic rats was shown by three additional experiments. The first involved receptor saturation by injection of 10 U native insulin 2 min before the tracer injection, resulting in identical [(3)H]insulin disappearance rates in the two groups of rats. The second consisted of displacing [(3)H]insulin from receptors by injecting 10 U unlabeled insulin 6 min after the tracer injection. Displacement of intact [(3)H]insulin from receptors and subsequent reappearance in the circulation occurred in both control and diabetic animals; however, such displacement was 25% greater in the diabetic rats. Finally, treatment of diabetic rats with insulin for 8 d normalized [(3)H]insulin clearance even though the tracer was injected at a time when the animals were again hyperglycemic and hypoinsulinemic. This suggests that down-regulation of insulin receptors had occurred during insulin therapy. These results confirm that a specific compartment for insulin exists (the insulin-receptor compartment) and that this compartment plays an important role in insulin clearance.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6451633      PMCID: PMC370616          DOI: 10.1172/JCI110082

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  36 in total

1.  Effects of streptozotocin-induced diabetes on insulin binding, glucose transport, and intracellular glucose metabolism in isolated rat adipocytes.

Authors:  M Kobayashi; J M Olefsky
Journal:  Diabetes       Date:  1979-02       Impact factor: 9.461

2.  Biological potency and binding affinity of monoiodoinsulin with iodine in tyrosine A14 or tyrosine A19.

Authors:  J Gliemann; O Sonne; S Linde; B Hansen
Journal:  Biochem Biophys Res Commun       Date:  1979-04-27       Impact factor: 3.575

3.  Insulin binding and degradation by muscles from streptozotocin-diabetic rats.

Authors:  W C Duckworth; D Gifford; A E Kitabchi; K Runyan; S S Solomon
Journal:  Diabetes       Date:  1979-08       Impact factor: 9.461

4.  Pharmacokinetics of subcutaneously injected tritiated insulin: effects of exercise.

Authors:  M Berger; P A Halban; J P Assal; R E Offord; M Vranic; A E Renold
Journal:  Diabetes       Date:  1979-01       Impact factor: 9.461

5.  Intraportal islet transplantation: functional assessment in conscious unrestrained rats.

Authors:  E R Trimble; E G Siegel; H R Berthoud; A E Renold
Journal:  Endocrinology       Date:  1980-03       Impact factor: 4.736

6.  Mobilization of subcutaneously injected tritiated insulin in rats: effects of muscular exercise.

Authors:  M Berger; P A Halban; W A Muller; R E Offord; A E Renold; M Vranic
Journal:  Diabetologia       Date:  1978-08       Impact factor: 10.122

7.  Compartmental analysis--I: LINDE, a program using an analytical method of integration with constituent matrices.

Authors:  J Estreicher; C Revillard; J R Scherrer
Journal:  Comput Biol Med       Date:  1979       Impact factor: 4.589

8.  Absorption kinetics of subcutaneously injected insulin. Evidence for degradation at the injection site.

Authors:  M Berger; P A Halban; L Girardier; J Seydoux; R E Offord; A E Renold
Journal:  Diabetologia       Date:  1979-08       Impact factor: 10.122

9.  Distribution and metabolism of intravenously injected tritiated insulin in rats.

Authors:  P A Halban; M Berger; R E Offord
Journal:  Metabolism       Date:  1979-11       Impact factor: 8.694

10.  Effect of fasting and streptozotocin diabetes on insulin binding and action in the isolated mouse soleus muscle.

Authors:  Y Le Marchand-Brustel; P Freychet
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

View more
  10 in total

1.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

2.  Insulin degrading enzyme activity and insulin binding of erythrocytes in normal subjects and Type 2 (non-insulin-dependent) diabetic patients.

Authors:  E Standl; H J Kolb
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

3.  Insulin-like growth factor-I and more potent variants restore growth of diabetic rats without inducing all characteristic insulin effects.

Authors:  F M Tomas; S E Knowles; P C Owens; C S Chandler; G L Francis; F J Ballard
Journal:  Biochem J       Date:  1993-05-01       Impact factor: 3.857

4.  In vivo imaging and quantitative analysis of insulin-receptor interaction in lean and obese Zucker rats.

Authors:  J C Sodoyez; F Sodoyez-Goffaux; S Treves; C R Kahn; R von Frenckell
Journal:  Diabetologia       Date:  1984-03       Impact factor: 10.122

5.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects.

Authors:  R Prager; P Wallace; J M Olefsky
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

6.  Receptor- and non-receptor-mediated uptake and degradation of insulin by hepatocytes.

Authors:  D B Donner
Journal:  Biochem J       Date:  1982-10-15       Impact factor: 3.857

7.  Effect of receptor up-regulation on insulin pharmacokinetics in streptozotocin-treated diabetic rats.

Authors:  H Sato; T Terasaki; K Okumura; A Tsuji
Journal:  Pharm Res       Date:  1991-05       Impact factor: 4.200

8.  Differing effects of antiinsulin serum and antiinsulin receptor serum on 123I-insulin metabolism in rats.

Authors:  J C Sodoyez; F Sodoyez Goffaux; R von Frenckell; C J De Vos; S Treves; C R Kahn
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808

9.  The Insulin Receptor Mediates Insulin's Early Plasma Clearance by Liver, Muscle, and Kidney.

Authors:  Rick I Meijer; Eugene J Barrett
Journal:  Biomedicines       Date:  2021-01-05

10.  Ultrastructure of the liver microcirculation influences hepatic and systemic insulin activity and provides a mechanism for age-related insulin resistance.

Authors:  Mashani Mohamad; Sarah Jayne Mitchell; Lindsay Edward Wu; Melanie Yvonne White; Stuart James Cordwell; John Mach; Samantha Marie Solon-Biet; Dawn Boyer; Dawn Nines; Abhirup Das; Shi-Yun Catherine Li; Alessandra Warren; Sarah Nicole Hilmer; Robin Fraser; David Andrew Sinclair; Stephen James Simpson; Rafael de Cabo; David George Le Couteur; Victoria Carroll Cogger
Journal:  Aging Cell       Date:  2016-04-20       Impact factor: 9.304

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.